Multiple sclerosis showing elevation of adenosine deaminase levels in the cerebrospinal fluid

被引：11

作者：

Samuraki, Miharu ^{[1
]}

Sakai, Kenji ^{[1
]}

Odake, Yasuko ^{[3
]}

Yoshita, Mitsuhiro ^{[3
]}

Misaki, Kouichi ^{[2
]}

Nakada, Mitsutoshi ^{[2
]}

Yamada, Masahito ^{[1
]}

机构：

[1] Kanazawa Univ, Grad Sch Med Sci, Dept Neurol & Neurobiol Aging, Kanazawa, Ishikawa, Japan

[2] Kanazawa Univ, Dept Neurosurg, Kanazawa, Ishikawa, Japan

[3] Hokuriku Univ, Natl Hosp Org, Dept Neurol, Kanazawa, Ishikawa, Japan

来源：

MULTIPLE SCLEROSIS AND RELATED DISORDERS | 2017年 / 13卷

关键词：

Multiple sclerosis; Adenosine deaminase; Tuberculosis; Cerebrospinal fluid; Brain biopsy;

D O I：

10.1016/j.msard.2017.02.005

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

An 80-year-old man developed dysarthria, quadriplegia, sensory disturbance and ataxia in all limbs. Brain and spinal magnetic resonance imaging (MRI) revealed multiple enhanced lesions. Cerebrospinal fluid (CSF) levels of adenosine deaminase (ADA) remarkably elevated. Tuberculosis DNA was not detected, and tuberculosis was not cultured either in the CSF. Brain biopsy revealed the inflammatory demyelinating lesions. With the diagnosis of multiple sclerosis, corticosteroid therapy resulted in rapid improvement of his symptoms and MRI abnormalities. CSF levels of ADA also decreased. Multiple sclerosis should be included in differential diagnosis of disorders with ADA elevation in the CSF.

引用

页码：44 / 46

页数：3

共 50 条

[21] Cerebrospinal fluid pleocytosis in multiple sclerosis patients with lesions showing reduced diffusion
Eisele, Philipp
Szabo, Kristina
Griebe, Martin
Wolf, Marc E.
Hennerici, Michael G.
Gass, Achim
[J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (10) : 1391 - 1395
[22] Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis
Piazza, F.
DiFrancesco, J. C.
Fusco, M. L.
Corti, D.
Pirovano, L.
Frigeni, B.
Mattavelli, L.
Andreoni, S.
Frigo, M.
Ferrarese, C.
Tredici, G.
Cavaletti, G.
[J]. JOURNAL OF NEUROIMMUNOLOGY, 2010, 220 (1-2) : 104 - 107
[23] Increased glycine levels in cerebrospinal fluid of patients with multiple sclerosis
Durfinova, Monika
Bartova, Radka
Oresanska, Katarina
Turecky, Ladislav
Prochazkova, L'ubica
Petrlenicova, Darina
Liska, Branislav
[J]. CLINICA CHIMICA ACTA, 2018, 486 : 86 - 87
[24] Serum and cerebrospinal fluid cytokine levels in patients with multiple sclerosis
Havrdova, E
Jedlicka, P
Hana, I
Kalanin, J
[J]. CESKA A SLOVENSKA NEUROLOGIE A NEUROCHIRURGIE, 1995, 58 (06): : 271 - 276
[25] Elevated levels of osteopontin in the cerebrospinal fluid of patients with multiple sclerosis
Braitch, M
Nunan, R
Niepel, G
Constantinescu, CS
[J]. MULTIPLE SCLEROSIS JOURNAL, 2004, 10 : S170 - S170
[26] Cerebrospinal fluid mitochondrial DNA levels in patients with multiple sclerosis
Fissolo, Nicolas
Cervera-Carles, Laura
Villar Guimerans, Luisa Maria
Lleo, Alberto
Clarimon, Jordi
Drulovic, Jelena
Dujmovic, Irena
Voortman, Margarete
Khalil, Michael
Gil, Elia
Navarro, Laura
Carlos Alvarez-Cermeno, Jose
Montalban, Xavier
Comabella, Manuel
[J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (11) : 1535 - 1538
[27] Increased osteopontin levels in the cerebrospinal fluid of patients with multiple sclerosis
Braitch, Manjit
Nunan, Robert
Niepel, Graham
Edwards, Laura J.
Constantinescu, Cris S.
[J]. ARCHIVES OF NEUROLOGY, 2008, 65 (05) : 633 - 635
[28] ADENOSINE-DEAMINASE LEVELS IN CEREBROSPINAL-FLUID IN TUBERCULOSIS AND BACTERIAL-MENINGITIS - REPLY
DONALD, PR
[J]. TUBERCLE AND LUNG DISEASE, 1995, 76 (04): : 373 - 373
[29] The Cerebrospinal Fluid in Multiple Sclerosis
Deisenhammer, Florian
Zetterberg, Henrik
Fitzner, Brit
Zettl, Uwe K.
[J]. FRONTIERS IN IMMUNOLOGY, 2019, 10
[30] Cerebrospinal fluid in multiple sclerosis
Rammohan, Kottil W.
[J]. ANNALS OF INDIAN ACADEMY OF NEUROLOGY, 2009, 12 (04) : 246 - 253

← 1 2 3 4 5 →